Xenetic Biosciences Inc.

NASDAQ: XBIO · Real-Time Price · USD
2.86
-0.06 (-2.22%)
At close: Aug 15, 2025, 3:58 PM
2.96
3.50%
After-hours: Aug 15, 2025, 06:02 PM EDT

Xenetic Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.5M 2.54M 1.71M 1.16M
Cost of Revenue
n/a n/a 27.04K 35.48K
Gross Profit
2.5M 2.54M 1.68M 1.13M
Operating Income
-4.2M -4.52M -6.72M -5.75M
Interest Income
249.86K 355.76K 167.15K 100.47K
Pretax Income
-3.96M -4.13M -6.55M -5.65M
Net Income
-3.96M -4.13M -6.39M -5.54M
Selling & General & Admin
3.42M 3.56M 3.65M 3.74M
Research & Development
3.29M 3.49M 4.77M 3.16M
Other Expenses
n/a n/a -1.6K 1.12K
Operating Expenses
6.7M 7.06M 8.42M 6.91M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
6.7M 7.06M 8.42M 6.91M
Income Tax Expense
n/a n/a -165.56K -100.47K
Shares Outstanding (Basic)
1.54M 1.53M 1.42M 1.03M
Shares Outstanding (Diluted)
1.54M 1.53M 1.42M 1.03M
EPS (Basic)
-2.57 -2.71 -4.49 -5.39
EPS (Diluted)
-2.57 -2.71 -4.49 -5.39
EBITDA
-4.2M -4.52M -6.72M -5.71M
EBIT
-4.2M -4.52M -6.72M -5.75M
Depreciation & Amortization
153.34K -28.21K 27.04K 35.48K